Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof

Details for Australian Patent Application No. 2006224789 (hide)

Owner Innogenetics N.V.

Inventors Bozdayi, Mithat

Agent Davies Collison Cave

Pub. Number AU-B-2006224789

PCT Pub. Number WO2006/097285

Priority 05101997.4 15.03.05 EP; 60/661,484 15.03.05 US

Filing date 14 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 6 September 2012

International Classifications

C07K 14/02 Peptides having more than 20 amino acids

C12N 7/00 Viruses, e.g. bacteriophages

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/097285 Priority application(s): WO2006/097285

6 September 2012 Application Accepted

  Published as AU-B-2006224789

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224792-Nutritional compositions for modulating Vitamin C bio-availability

2006224788-Variants of Hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof